 |
Stevens Johnson Syndrome and Toxic Epidermal Necrolysis
We are currently investigating potential claims on behalf of people who developed Stevens Johnson Syndrome (SJS) or Toxic Epidermal Necrolysis (TEN) as a result of exposure to certain pharmaceuticals, particularly Dilantin®, Phenytek®, Cerebyx® and Tegretol®.
On November 24th, 2008 the FDA issued a MedWatch Alert informing healthcare providers of a potential increased risk of serious skins reactions associated with the use of Dilantin®, Phenytek®, Cerebyx® and Tegretol® by certain patients of Asian descent. In December, 2007, the FDA described an increased risk of SJS and TEN associated with another anti-epileptic drug, Tegretol® (carbamazepine) in patients of Asian descent.
If you or a loved one developed SJS or TEN while taking Dilantin®, Phenytek®, Cerebyx® and Tegretol® please contact us by completing and submitting our E-CONTACT Form. We will contact you promptly - in all events, within 24 hours.
Dilantin®, Phenytek® and Cerebyx®
Dilantin® and Phenytek® are widely prescribed anti-epileptic medications commonly referred to as phenytoins. Cerebyx®, also an anti-epileptic treatment, is an injectable medication and commonly referred to as fosphenytoin.
Each of these medications is used as an alternative to Tegretol® (carbamazepine), an anti-epileptic/anti-convulsive treatment that has been associated with SJS and TEN. However, there have been reports that patients taking Dilantin®, Phenytek® and Cerebyx® have also developed SJS and TEN. Patients of Asian descent may be at increased risk of SJS and TEN when taking these medications.
Meneo Law Group's team of dedicated professionals strives for excellence in all that we do. Our mission is to provide our clients with effective, professional and thorough legal representation and to do so in a diligent and ethical manner that helps our clients achieve and maximize their legal objectives.
|
|
 |
|
Stevens-Johnson Syndrome (SJS)/Toxic Epidermal Necrolysis (TEN)
SJS and TEN are related, but distinct serious skin disorders the initial onset of which produce cough, body aches, fever and headache. A red skin rash then appears on the face and/or torso which oftentimes spreads and forms blisters.
With SJS, blistering of mucous membranes such as the lips, mouth, eyes and other such "mucosa" appears with perhaps 10% of the body being affected. Blistering also occurs with TEN. However, large areas of skin become very painful and will peel off – sometimes with even the slightest touch.
SJS and TEN can be life-threatening so early detection and treatment are critical. If you are currently taking Dilantin®, Phenytek® or Cerebyx® and have questions or concerns about your medications, you should contact your healthcare provider/prescriber.
No-Cost Review:
If you or a loved one developed SJS or TEN while taking Dilantin®, Phenytek® or Cerebyx® and have questions about your legal rights or those of your loved one, please contact us by completing and submitting our E-CONTACT Form. We will contact you promptly - in all events, within 24 hours.
DISCLAIMER
|
|
|
 |
 
|
If you or a loved one developed SJS or TEN while taking Dilantin®, Phenytek® or Cerebyx® and have questions about your legal rights or those of your loved one, please contact us by completing and submitting our E-CONTACT Form.
We will contact you promptly - in all events, within 24 hours.
|
|
|
|
